As of 2025-07-06, the Relative Valuation of NGM Biopharmaceuticals Inc (NGM) is (20.86) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.54 USD, the upside of NGM Biopharmaceuticals Inc based on Relative Valuation is -1454.2%.
The range of the Relative Valuation is (18.39) - (22.69) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.0x - 13.3x | 11.0x |
| Forward P/E multiples | 10.8x - 17.0x | 13.5x |
| Fair Price | (18.39) - (22.69) | (20.86) |
| Upside | -1294.2% - -1573.3% | -1454.2% |
| Date | P/E |